Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY27.83 CNY
Change Today -3.09 / -9.99%
Volume 5.1M
As of 3:00 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

shanxi c&y pharmaceutical-a (300254) Snapshot

Open
CNY28.60
Previous Close
CNY30.92
Day High
CNY30.46
Day Low
CNY27.83
52 Week High
06/15/15 - CNY65.48
52 Week Low
07/25/14 - CNY15.17
Market Cap
4.5B
Average Volume 10 Days
5.2M
EPS TTM
CNY0.26
Shares Outstanding
160.6M
EX-Date
06/15/15
P/E TM
109.0x
Dividend
CNY0.08
Dividend Yield
0.30%
Current Stock Chart for SHANXI C&Y PHARMACEUTICAL-A (300254)

Related News

No related news articles were found.

shanxi c&y pharmaceutical-a (300254) Related Businessweek News

No Related Businessweek News Found

shanxi c&y pharmaceutical-a (300254) Details

Shanxi C&Y Pharmaceutical Group Co., LTD. researches, develops, manufactures, and distributes pharmaceuticals in China. Its principle products include anti-infective agents, respiratory system agents, cardiovascular drugs, antidepressant drugs, antimicrobials, anti-inflammatory drugs, chronic medication, and other drugs, as well as pharmaceutical raw materials and pharmaceutical intermediates. The company was formerly known as Shanxi C&Y Pharmaceutical Co., LTD. and changed its name to Shanxi C&Y Pharmaceutical Group Co., LTD. in September 2014. Shanxi C&Y Pharmaceutical Group Co., LTD. was founded in 2005 and is based in Datong, China.

Founded in 2005

shanxi c&y pharmaceutical-a (300254) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanxi c&y pharmaceutical-a (300254) Key Developments

Shanxi C&Y Pharmaceutical Group Co.,Ltd. Announces Tax Included Final Cash Dividend for the Year 2014, Payable on June 15, 2015

Shanxi C&Y Pharmaceutical Group Co.,Ltd. announced tax included final cash dividend of CNY 1.0000000 per 10 shares for the year 2014. The dividend will be paid on June 15, 2015 with record date as June 12, 2015 and ex-date as June 15, 2015. Net cash dividend for 10 shares after tax was CNY 0.90000000.

Shanxi C&Y Pharmaceutical Group Co.,Ltd. to Report Q1, 2015 Results on Apr 23, 2015

Shanxi C&Y Pharmaceutical Group Co.,Ltd. announced that they will report Q1, 2015 results on Apr 23, 2015

Shanxi C&Y Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for the Year 2014

Shanxi C&Y Pharmaceutical Group Co.,Ltd. announced that at the Annual General Meeting held on approved the cash dividend of CNY 1.0 per ten shares tax included for the year 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300254:CH CNY27.83 CNY -3.09

300254 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300254.
View Industry Companies
 

Industry Analysis

300254

Industry Average

Valuation 300254 Industry Range
Price/Earnings 100.0x
Price/Sales 8.4x
Price/Book 8.5x
Price/Cash Flow 133.0x
TEV/Sales 7.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANXI C&Y PHARMACEUTICAL-A, please visit www.cy-pharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.